Ololiuqui Seed

Ololiuqui seeds contain D-lysergic acid amide (ergine) and D-isolysergic acid amide as primary bioactive compounds. These ergoline alkaloids activate dopamine D2 receptors, producing psychoactive effects 50-100 times weaker than LSD with 4-8 hour duration.

Category: Seed Evidence: 8/10 Tier: Tier 1 (authoritative)
Ololiuqui Seed — Hermetica Encyclopedia

Origin & History

Turbina corymbosa, commonly known as Ololiuqui, is a morning glory vine native to tropical and subtropical regions of Central and South America. It thrives along forest edges and riverbanks. Its seeds have been historically significant in Mesoamerican spiritual and medicinal practices.

Historical & Cultural Context

Ololiuqui Seed holds profound historical and cultural significance in Mesoamerican traditions, particularly among the Aztec. It was honored in spiritual ceremonies for fostering higher consciousness, emotional healing, and cognitive clarity, and used medicinally for various ailments.

Health Benefits

- Supports cognitive clarity and mental focus, traditionally used for introspection.
- Promotes emotional balance and stress resilience through its unique alkaloid profile.
- Contributes to cardiovascular health via polyunsaturated fatty acids.
- Aids digestive wellness and regularity with its fiber and saponin content.
- Enhances immune resilience through various phytochemicals.
- Supports joint health by modulating inflammatory pathways.

How It Works

The primary compound D-lysergic acid amide (ergine) activates dopamine D2 receptors, inhibiting adenylate cyclase and reducing cAMP formation. This mechanism produces altered consciousness states and disrupted wakefulness patterns. Secondary compounds include D-isolysergic acid amide and various phenolic compounds with reported antioxidant and anti-inflammatory properties.

Scientific Research

Research on Ololiuqui Seed, primarily ethnobotanical and phytochemical analyses, focuses on its ergoline alkaloid content and traditional psychoactive uses. Preliminary studies suggest potential for cognitive and emotional support, but extensive human clinical trials are lacking and caution is advised due to its potent compounds.

Clinical Summary

Current research on ololiuqui seeds consists primarily of ethnobotanical and phytochemical analyses rather than controlled human trials. No specific clinical trial data with quantified results, sample sizes, or standardized dosing protocols are available in peer-reviewed literature. Preliminary studies suggest potential cognitive and emotional effects through ergoline alkaloid activity, but extensive human clinical validation remains lacking. The evidence base is limited to traditional use documentation and basic pharmacological characterization of active compounds.

Nutritional Profile

- Phytochemicals: Ergoline alkaloids (ergine/LSA), flavonoids, phenolic acids, saponins.
- Lipids: Polyunsaturated fatty acids.
- Minerals: Magnesium, potassium, calcium.

Preparation & Dosage

- Common Forms: Whole seeds, standardized extract.
- Traditional Use: Used by Aztec and Mesoamerican cultures in spiritual ceremonies, for emotional healing, and medicinal treatment of headaches, fever, and digestive issues.
- Modern Applications: Incorporated into nootropic supplements, adaptogenic blends, and cognitive-supporting formulations.
- Dosage: 100–200 mg of standardized extract daily, strictly under professional supervision due to its potent psychoactive compounds.
- Important Note: Contains psychoactive ergoline alkaloids; use only under professional guidance.

Synergy & Pairings

Role: Fat + fiber base
Intention: Cardio & Circulation | Cognition & Focus
Primary Pairings: - Turmeric (Curcuma longa)
- Ginger (Zingiber officinale)
- Chia Seeds
- Camu Camu

Safety & Interactions

Ololiuqui seeds contain potent ergot alkaloids that may cause serious adverse effects, requiring extreme caution in any use. The ergoline compounds have documented toxic effects alongside their psychoactive properties, particularly in uncontrolled dosing. Potential interactions with MAO inhibitors (MAOIs) exist, though specific interaction profiles for ergine remain incompletely characterized. Pregnancy, breastfeeding, cardiovascular conditions, and psychiatric disorders represent absolute contraindications due to the psychoactive nature and safety concerns.